
s’ Note
Articles
-
Jan 10, 2025 |
journals.sagepub.com | s’ Note |Conrad Hackett |Yunping Tong
During the Cultural Revolution, religion was banned in China. When restrictions receded in the 1980s and 1990s, religion flourished as China entered into an era of economic reform and opened up to the world (Goossaert and Palmer 2011). Among China’s major religions, Christianity experienced the most prominent growth (Aikman 2006; Bays 2012).
-
Oct 24, 2024 |
journals.sagepub.com | s’ Note |Esther Chan |Di Di
In 2021, Forbes published an opinion titled “Could Religion Be Fueling the Gender Pay Gap?” (Webster 2021). Two years later, Le Monde, a French newspaper, published a similar opinion questioning whether religions “legitimize inequality between men and women” (Larousse 2023).
-
Jun 5, 2023 |
tinyurl.com | s’ Note |Louis P. Garrison |Adrian Towse
The Inflation Reduction Act (IRA) of 2022 Section 1193 states that when engaging in drug price negotiation, the Secretary of Health and Human Services should consider, among multiple factors, manufacturer-submitted data on the drug’s “research and development costs,” as well as “the extent to which the manufacturer has recouped research and development [R&D] costs.” And in its initial March 15, 2023, guidance for implementation of the Negotiation Program, the Centers for Medicare and Medicaid...
-
May 18, 2023 |
rti.org | s’ Note
As the landscape of integrated care models continues to evolve, it begs the question—do these integrated care models deliver better outcomes compared to non-integrated MA plans? Research Assessing The Effects Of Integrated Care Models Is LimitedBased on a review of studies published between 2004 and 2020, the Medicaid and CHIP Payment and Access Commission (MACPAC) reported mixed findings regarding the effectiveness of integrated care models.
-
May 4, 2023 |
tinyurl.com | s’ Note |Jason Shafrin |Darius Lakdawalla |Jalpa A. Doshi
Medicare drug price negotiation is almost upon us. The Inflation Reduction Act (IRA) mandates that the Centers for Medicare and Medicaid Services (CMS) implement a maximum fair price (MFP) for drug price negotiation beginning in 2026. How should CMS implement such a program given such a short timeline? We recommend a three-step approach to implementing the MFP that moves toward a drug pricing paradigm based on treatment value.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →